Cargando…
Clinical use of tranexamic acid: evidences and controversies
Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical procedures and improves survival rates in obstetric and trauma patients with severe bleeding. Although it mainly acts as a fibrinolysis inhibitor, it also has an anti-inflammatory effect, and may help attenuate the sy...
Autores principales: | Colomina, Maria J., Contreras, Laura, Guilabert, Patricia, Koo, Maylin, M..ndez, Esther, Sabate, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660007/ https://www.ncbi.nlm.nih.gov/pubmed/34626756 http://dx.doi.org/10.1016/j.bjane.2021.08.022 |
Ejemplares similares
-
Tranexamic acid evidence and controversies: An illustrated review
por: Relke, Nicole, et al.
Publicado: (2021) -
Proteasome inhibitors in the treatment of nonsmall cell lung cancer: A systematic review of clinical evidence
por: Chua, Alethea Dasha Wenning, et al.
Publicado: (2023) -
Dance/Movement Therapy and the Arts in Healthcare: The First 50 Years
por: Goodill, Sherry W.
Publicado: (2016) -
Perspective from a Patient Partner
por: Gaetz, Lyn
Publicado: (2020) -
How COVID-19 Is Testing and Evolving Our Communication Skills
por: Julka-Anderson, Naman
Publicado: (2020)